FDA approves CyPass micro-stent system for use with cataract surgery

The FDA has approved the CyPass micro-stent system for use in combination with cataract surgery to reduce IOP in adult patients with mild to moderate primary open angle glaucoma, according to a news release from the agency’s Center for Devices and Radiological Health. The CyPass micro-stent system model 241-S (Alcon, a division of Novartis) includes the CyPass micro-stent, a loading device and a stent delivery tool. The micro-stent is placed in the angle of the eye with the distal end residing in the supraciliary space to allow outflow of fluid from the anterior chamber through the distal end into the supraciliary and suprachoroidal spaces.